Cargando…
Effects of Holding Beta-Blockers on the Vital Signs of Heart Failure Patients
BACKGROUND: Heart failure with reduced ejection fraction (HFrEF) is associated with recurrent hospitalizations and high mortality. Guideline-directed medical therapy (GDMT) reduces morbidity, mortality and re-admission rates. Despite the evidence, less than 50% of patients with HFrEF are prescribed...
Autores principales: | Erickson, Marc, O’Dell, Kimberly, Malpartida, Juan Carlos, Mok, Jacob, Khan, Rafay, Patel, Dharmendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781264/ https://www.ncbi.nlm.nih.gov/pubmed/33447319 http://dx.doi.org/10.14740/cr1169 |
Ejemplares similares
-
Thyroid and Cardiovascular Disease: A Focused Review on the Impact of Hyperthyroidism in Heart Failure
por: Khan, Rafay, et al.
Publicado: (2020) -
Vascular comorbidities worsen prognosis of patients with heart failure hospitalised with COVID-19
por: Mok, Jacob, et al.
Publicado: (2021) -
Beta-Blockers and Oxidative Stress in Patients with Heart Failure
por: Nakamura, Kazufumi, et al.
Publicado: (2011) -
New advances in beta-blocker therapy in heart failure
por: Barrese, Vincenzo, et al.
Publicado: (2013) -
The effect of beta-blockers in acute heart failure according to heart rate
por: Kim, Hyun-Jin, et al.
Publicado: (2021)